文献速递咽喉与嗓音

声带麻痹声带内注射曲拉弗明后嗓音改善的预测因素

Predictors of Voice Improvement After Intracordal Trafermin Injection in Vocal Fold Paralysis.
PubMed 文献 · Laryngoscope · 2025-07-17

这项回顾性研究分析了143例单侧声带麻痹患者在东京嗓音中心接受声带内曲拉弗明注射的资料,比较首次注射后无需(A组)与需要(B组)额外治疗的两组。注射前最大发声时间、音域和平均气流率在两组间差异显著,并计算了截止值;logistic回归未显示任何因素有显著差异。作者认为这些注射前指标可能有助于指导治疗决策。

要点

  • 注射前MPT、PR、MFR在需与无需额外治疗的两组间差异显著(p分别<0.01、0.02、0.01)。
  • 截止值:MPT 3.25 s、PR 20.5半音、MFR 597.8 mL/s。
  • Logistic回归显示所评估因素均无显著差异。

核心结论

  • 注射前MPT、PR和MFR可能有助于指导单侧声带麻痹声带内曲拉弗明注射的决策,并可能帮助患者选择最佳治疗方案。

研究设计与样本

  • 回顾性研究,评估2012年至2024年间在东京嗓音中心接受声带内曲拉弗明注射的308例单侧声带麻痹患者的病历,最终分析143例患者数据。

主要发现

  • A组(首次注射后无需额外治疗)与B组(需要额外治疗)的MPT、PR和MFR差异显著,p值分别为<0.01、0.02和0.01。
  • 基于上述参数计算截止值:MPT为3.25 s,PR为20.5半音,MFR为597.8 mL/s。
  • Logistic回归显示所评估的任何因素均无显著差异。

关键数值与推荐

  • 注射前MPT截止值3.25 s,PR截止值20.5半音,MFR截止值597.8 mL/s。

临床怎么用

  • 作者认为,注射前MPT、PR和MFR可能有助于指导单侧声带麻痹声带内曲拉弗明注射的治疗决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Following intracordal trafermin injection for unilateral vocal fold paralysis, some patients require further treatment owing to poor voice improvement. This study aimed to identify the pre-injection factors predictive of the effectiveness of intracordal trafermin injection for unilateral vocal fold paralysis. METHODS: This retrospective study evaluated the medical records of 308 patients diagnosed with unilateral vocal fold paralysis who received intracordal trafermin injections at the Tokyo Voice Center between 2012 and 2024. Data from 143 patients were finally analyzed. To predict the efficacy of intracordal trafermin injection on voice improvement prior to trafermin administration, several related factors were evaluated: age, sex, causative diseases, and pre- and post-injection data, including the maximum phonation time (MPT), pitch range (PR), mean flow rate (MFR), and voice handicap index (VHI). Patients were divided into two groups depending on whether additional treatment was not (Group A) or was (Group B) required after the first injection. RESULTS: MPT, PR, and MFR differed significantly between Group A and Group B (p < 0.01, 0.02, and 0.01, respectively); subsequently, cutoff values were calculated using these parameters. The cutoff values were 3.25 s for MPT, 20.5 semitones for PR, and 597.8 mL/s for MFR. Logistic regression showed no significant differences in any of the factors. CONCLUSION: The pre-injection MPT, PR, and MFR may help guide decisions regarding of intracordal trafermin injection in the treatment of unilateral vocal fold paralysis. These factors could help inform optimal treatment decision making for patients.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Hasegawa T, Aluariachy L, Fujita R, et al. Predictors of Voice Improvement After Intracordal Trafermin Injection in Vocal Fold Paralysis. Laryngoscope. 2025. PMID: 40673598. doi:10.1002/lary.32436

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。